Olympus
Olympus was founded in 1919 and launched our first gastro-camera in the 1950s. Since then, Olympus developed into a MedTech leader, designing and delivering innovative solutions for medical and surgical procedures, especially in the field of endoscopy.
Felicia Chung
APAC Region Business Development LeadOniX Hub
OniX invest in companies in two ways: (1) Directly through it OniX Venture Fund and (2) Indirectly through its OniX hub members (includes pharma, VC, PE, family offices and private foundations)
Martin Duenas
Founder/CEOOpera CRO, a TIGERMED company
Opera CRO is an international contract research organization (CRO) with offices in Italy (Genoa), in Switzerland (Geneva) and in Romania (Timisoara) that has been managing clinical trials since 1995. In particular, we performed several clinical studies with medical devices, medical drugs and food supplements in many different therapeutic areas.
We offer the possibility of conducting clinical trials in different countries in Eastern Europe, with reduced costs and faster times, or in other European and non-European countries (Italy, France, Switzerland, Germany etc..). Additionally, we offer specific support for the compliance of medical device registrations of the CE marking to the new European regulation. Recently, Opera CRO was acquired by the Tigermed group, the largest CRO in Asia with over 5000 employees and 100 offices. This partnership offers the opportunity to perform clinical trials in China and in the rest of Asia and access that vast market.
The list of our current studies can be found on ClinicalTrial.gov (specifying Opera CRO for Europe, Tigermed for Asia); further information is available on our website: www.operacro.com.
We offer the possibility of conducting clinical trials in different countries in Eastern Europe, with reduced costs and faster times, or in other European and non-European countries (Italy, France, Switzerland, Germany etc..). Additionally, we offer specific support for the compliance of medical device registrations of the CE marking to the new European regulation. Recently, Opera CRO was acquired by the Tigermed group, the largest CRO in Asia with over 5000 employees and 100 offices. This partnership offers the opportunity to perform clinical trials in China and in the rest of Asia and access that vast market.
The list of our current studies can be found on ClinicalTrial.gov (specifying Opera CRO for Europe, Tigermed for Asia); further information is available on our website: www.operacro.com.